RecruitingNot ApplicableNCT06211348
Genomic Sequencing in Anatomically Normal Fetuses
Sponsor
University of California, San Francisco
Enrollment
1,000 participants
Start Date
Jan 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.
Eligibility
Min Age: 18 YearsMax Age: 64 Years
Inclusion Criteria4
- Pregnant patients who are:
- Pregnant with a structurally normal fetus (singleton or multiple gestation)
- Planning to undergo prenatal diagnosis by either chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine indications
- Planning, or have already completed expanded carrier screening
Exclusion Criteria4
- Pregnant patients who:
- Decline prenatal diagnostic testing
- Are pregnant and their fetus has a known anomaly
- Declined chromosomal microarray analysis of expanded carrier screening
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEGenomic Sequencing
Individuals who request prenatal diagnostic testing with standard chromosomal microarray will be offered genomic sequencing (GS) as an option to assess for additional disease risk.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06211348